Comparison Of External Physical Vibration Lithecbole(EPVL) In Different Time After Retrograde Intrarenal Surgery(RIRS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02890225|
Recruitment Status : Completed
First Posted : September 7, 2016
Last Update Posted : May 1, 2018
|Condition or disease||Intervention/treatment||Phase|
|Calculi||Procedure: 3 days after Procedure: 10days after Procedure: EPVL performed in30days after RIRS||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||1 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Supportive Care|
|Official Title:||Effect Of Renal Residual Stones c Treated By External Physical Vibration Lithecbole(EPVL) In m Different Time n After Retrograde Intrarenal w Surgery(RIRS):At y Multi-center z Prospective Randomized Controlled Trial|
|Study Start Date :||August 2016|
|Actual Primary Completion Date :||March 2017|
|Actual Study Completion Date :||March 2018|
Patients in 3 days
Procedure: 3 days after
in 3 days after RIRS.
Procedure: 10days after
in10 days after RIRS.
Procedure: EPVL performed in30days after RIRS
Patients in Group C undergo EPVL in630days after RIRS.
- Change from stone free rate(SFR) with different follow-up periods [ Time Frame: Patients in group A and group B return hospital respectively in 1,2 and 4 weeks after RIRS,patients in group C return hospital respectively in 2 and 4 weeks after RIRS. ]Primary SFR is assessed by abdominal plain film （KUB）in different follow-up periods after operation. Stone-free status are defined as either the absence of any residual stone fragments.
- Extracorporeal physical vibration complications [ Time Frame: Patients in group A and group B return hospital respectively in 1,2 and 4 weeks after RIRS,patients in group C return hospital respectively in 2 and 4 weeks after RIRS. ]Complication is defined as any adverse event occurred
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02890225
|The Second Affiliated Hospital of Zhengzhou University|
|Zhengzhou, Henan, China, 450014|
|Study Chair:||EB Wang, PH.D||The Second Affiliated Hospital of Zhengzhou University|